Concepedia

Lorraine Fang

LF

Statistics

Publications

1

Citations

82

H-Index

1

Active since

2015

Lorraine Fang is an author specializing in phase iii clinical trials, anti-inflammatory pharmacology, and inflammatory disease pharmacotherapy.

Publications per year

2015–2015

1

Publications

1

The Pharmacodynamic Impact of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, on Circulating Levels of Inflammatory Biomarkers in Patients with Psoriatic Arthritis: Substudy Results from a Phase III, Randomized, Placebo-Controlled Trial (PALACE 1)

Peter Schäfer, Peng Chen, Lorraine Fang et al. · Journal of Immunology Research · 2015 · 82 citations · Full text

, , +16

1–1 of 1